NCT00096785 - Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

April 30, 2008

Conditions

Hepatitis BChronic Disease

Interventions

DRUG

entecavir

Tablets, Oral, ETV 0.5 mg, once daily, up to 96 weeks

DRUG

adefovir

Tablets, Oral, ADV 10 mg, once daily, up to 96 weeks

Trial Locations (24)

Local Institution, San Diego

Local Institution, San Francisco

Local Institution, Torrance

Local Institution, Miami

Local Institution, North Miami Beach

Local Institution, Baltimore

Local Insitution, New York

Local Institution, New York

Local Institution, Philadelphia

Local Institution, Dallas

Local Institution, Galveston

Local Institution, Edmonton

Local Institution, Vancouver

Local Institution, Toronto

Local Institution, Chai Wan

Local Institution, Pokfulham

Local Institution, Tai Po

Local Institution, Jakarta

Local Institution, Cebu

Local Institution, Manila

Local Institution, Singapore

Local Institution, Taichung

Local Institution, Taoyan

Local Institution, Bangkok